Compounds > larusan
Page last updated: 2024-12-11

larusan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

larusan: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5334356
MeSH IDM0051944

Synonyms (13)

Synonym
3688-05-9
larusan
STK070508
n'-[(2e,3e)-4-(furan-2-yl)but-3-en-2-ylidene]pyridine-4-carbohydrazide
n-[(e)-[(e)-4-(furan-2-yl)but-3-en-2-ylidene]amino]pyridine-4-carboxamide
n'-(3-(2-furyl)-1-methyl-2-propenylidene)isonicotinic hydrazide
nsc 26272
isonicotinic acid, (3-(2-furyl)-1-methylallylidene)hydrazide
4-pyridinecarboxylic acid, (3-(2-furanyl)-1-methyl-2-propenylidene)hydrazide
AKOS005390071
SR-01000211533-1
sr-01000211533
n'-[4-(2-furyl)but-3-en-2-ylidene]isonicotinohydrazide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.89 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
acetone
methyl ketone : A ketone of formula RC(=O)CH3 (R =/= H).		6.9310ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
formaldehyde
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy		6.9310aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
isoniazid
Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.. hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).		2.8540carbohydrazideantitubercular agent;
drug allergen
ConditionIndicatedRelationship StrengthStudiesTrials
Mouth Diseases
Diseases involving the MOUTH.		01.9310
Koch's Disease
[description not available]		02.3320
Laryngeal Tuberculosis
[description not available]		01.9310
Tuberculosis
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.		02.3320